Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Lp(a)-Lowering Pelacarsen Shows Huge Disconnect With Cardiovascular Outcomes

(MedPage Today) -- Lowering lipoprotein(a), or Lp(a), did not translate into better cardiovascular outcomes in a secondary prevention population, at least not with pelacarsen in the Lp(a) HORIZON trial. Among people with elevated lipoprotein(a...

Lp(a)-Lowering Pelacarsen Shows Huge Disconnect With Cardiovascular Outcomes

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Saturday 7 November →